Matrix metallopeptidase 13 messenger RNA 3' untranslated region (MMP13 mRNA 3'-UTR)

The Matrix metallopeptidase 13 (MMP13) messenger RNA 3' untranslated region (3'-UTR) is a critical regulatory segment of the MMP13 transcript that governs its stability and translational efficiency. MMP13, also known as collagenase 3, is a potent enzyme responsible for the degradation of type II collagen, the primary structural component of articular cartilage (UniProt P45452). The 3'-UTR contains multiple binding sites for microRNAs, such as miR-140 and miR-27b, and various RNA-binding proteins that modulate the expression of the MMP13 protein in response to inflammatory stimuli (Miyaki et al., 2010, Genes & Dev). In diseases like osteoarthritis, the dysregulation of these regulatory interactions leads to the pathological overproduction of MMP13, resulting in irreversible cartilage destruction (PubMed: 20444847). Consequently, the MMP13 mRNA 3'-UTR has emerged as a therapeutic target for RNA-based interventions, including antisense oligonucleotides and miRNA mimics, aimed at reducing MMP13 levels to preserve joint integrity. Beyond joint disease, this target is also relevant in oncology, where MMP13 facilitates tumor invasion and metastasis by remodeling the extracellular matrix (PubMed: 25681505).

Other names

MMP13 3'-UTRMatrix metalloproteinase 13 mRNA 3'-UTRCollagenase 3 mRNA 3'-UTRMMP-13 3'-untranslated region

Targeting the MMP13 mRNA 3'-UTR typically involves the use of antisense oligonucleotides (ASOs) or microRNA (miRNA) mimics that bind to specific sequences within the region to induce mRNA degradation or inhibit translation, thereby reducing the production of the MMP13 enzyme.